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 ABSTRACT 
Purpose of review: surgical site infection (SSI) is a common health care associated infection 
and complicates up to 10-20% of operations with considerable health care resources. Apart 
from the widely adopted use of appropriate hair removal, antibiotic prophylaxis, avoidance of 
hypothermia and peri-operative glycaemic control to reduce SSIs this review has considered 
new research and systematic reviews, and whether their findings should be included in 
guidelines. 
Recent findings: The efficacy of preoperative bathing/showering, antibiotic prophylaxis for 
clean surgery and perioperative oxygen supplementation to reduce the risk of SSI is still in 
doubt. By contrast, the use of 2% chlorhexidine in alcohol skin preparation, postoperative 
negative pressure wound therapy and antiseptic surgical dressings do show promise. 
Antimicrobial sutures in independent meta-analyses were found to reduce the risk of SSI after 
all classes of surgery (except dirty) whereas the use of wound guards, or diathermy skin 
incision (compared with scalpel incision), did not.   
Summary: The incidence of SSI after surgery is not falling. Based on this review of published 
trials and evidence-based systematic reviews some advances might be included into these 
care bundles.  More research is needed together with improved compliance with care bundles.  
 
Key words: surgical site infection, antiseptics, antibiotic prophylaxis, surgical dressings, 
antimicrobial sutures 
INTRODUCTION.  Epidemiology and costs of SSIs                                                                                                         
Current epidemiological data indicates that the overall prevalence of Health Care Associated 
Infections (HCAIs) in England is 6.4% (CI 4.7-8.7%) with surgical site infections (SSIs) 
being the third most common category (15.7%) 
1, 2
. SSIs could be considered as being the 
most preventable HCAI, particularly when a care bundle approach, as there are many 
associated risk factors to target. A High Impact Intervention (HII) care bundle 
3
 issued by the 
Department of Health (DH, United Kingdom) is based on a guideline for the prevention and 
treatment of SSIs published by the National Institute for Heath and Clinical Excellence 
(NICE): a combination of systematic review, other published guidance, and expert advice 
4
. 
The HII care bundle incorporates core interventions of rational antibiotic prophylaxis, 
appropriate pre-operative hair removal, avoidance of perioperative hypothermia and peri-
operative glycaemic control in patients who have diabetes, together with other 
recommendations which are not of a level IA evidence base. An evidence update from NICE 
has since made no substantial changes to the recommendations published in the original 
guideline 
5
. Despite the introduction of this directive, and its recommendations, having been 
circulated for over five years no evaluation of compliance with it or its effectiveness has been 
published 
6
. 
The national SSI surveillance system, established and administered by Public Health England 
to enable hospitals to compare their SSI rates against a national benchmark, aims to use SSI 
data to improve the quality of patient care 
2
. Participating hospitals undertake surveillance in 
at least one of 17 categories of surgical procedures. In addition, the DH has mandated that 
acute NHS hospital trusts which perform orthopaedic surgery should undertake a minimum of 
three months of surveillance each year in at least one specified category 
7
. It has been 
suggested that the true prevalence of SSI is underestimated, depending on surgical specialty, 
accepted and validated definitions and the comprehensiveness of postoperative surveillance
 8-
9
. When close post-discharge surveillance is included, particularly with the involvement of 
unbiased, trained and validated observers, SSIs have been reported to complicate 10-20% of 
surgical operations indicating that there is widespread underestimation of SSI rates across all 
classes of surgery 
10-18
. 
SSIs are associated with over a third of postoperative deaths; they can range from a relatively 
trivial, short-lived, wound discharge (e.g., after open hernia surgery) to being life threatening 
(e.g., mediastinitis and sternal wound dehiscence) 
19
. In between there are the cosmetically 
unacceptable scars which may cause pain, prolonged duration, and expense of hospitalisation, 
and poor emotional wellbeing 
20
. Apart from the unrecorded indirect costs related to loss of 
productivity, reduced quality of life, and expensive litigation the actual cost of an SSI can 
involve many days of inpatient treatment and added procedures which can run into many 
thousands of pounds 
21, 22
. An example of this is the morbidity and mortality which may 
follow sternal infection after cardiac surgery 
23
. There is a paucity of prospective cost-benefit 
analysis of SSIs, but retrospective analyses clearly identify that the economic costs of SSI are 
substantial 
24
.  
There has been further research published since the NICE guideline recommendations were 
introduced: some presents new data or promising new technology which could be considered 
for guideline inclusion and the HII for SSIs; some has been shown to be clearly unhelpful in 
the prevention of SSIs and the rest has not added to the evidence already in place. Much of 
this is reflected in a NICE evidence update 
5
. Review of the most relevant aspects of this new 
information is the topic of this article.     
 
Preoperative bathing and skin preparation 
Ensuring personal hygiene of the operative team and surgical patient on the day of surgery is 
not controversial but the role of preoperative bathing and skin preparation with antiseptics to 
prevent SSIs is unproven. A Cochrane review of seven randomised controlled trials (RCTs; 
(n=10,157 patients) 
25
 found that preoperative showering or bathing with chlorhexidine was 
found to be no more effective than placebo, soap or no washing. Most of the studies included 
were over 20 years old. A further systematic review of 10 studies (n=7,351) 
26
 examined the 
effects of the number of antiseptic showers, and type of antiseptics. No definitive conclusions 
could be made about the optimal number of preoperative showers but in eight of the studies, 
chlorhexidine led to a reduction in skin surface bioburden. There were many methodological 
flaws in the trials, many being underpowered. In addition, skin bacteria did not seem to 
necessarily correlate with SSI risk. Another systematic review of 20 randomised and non-
randomised studies (n=9,520) 
27 
evaluated three types of skin antiseptic (povidone-iodine, 
alcohol, or chlorhexidine) for patient skin preparation, operative team hand scrub procedure, 
preoperative showering or the use of antiseptic-impregnated incise drapes, prior to thoracic, 
cardiac, plastic, orthopaedic, neurological, abdominal, or pelvic surgery. Significant 
heterogeneity precluded meta-analysis but preoperative showering appeared to reduce skin 
surface bioburden but the effect on SSIs was inconclusive. Again there were multiple flaws in 
the studies including inconsistencies in the formulation, strength and application of 
antiseptics, with mixed quality and randomisation and the inclusion of a wide range of 
procedures. 
The benefits of preoperative bathing or showering with antiseptics to prevent SSIs are 
uncertain and only further large trials can improve this evidence base 
                                                                                                                                                                                                                       
Patient antiseptic skin preparation 
It is conventional practice to prepare patients’ skin at the surgical site immediately before 
incision using an antiseptic (such as povidone-iodine or chlorhexidine; aqueous or alcohol-
based). A Cochrane review 
28
 compared different preoperative skin preparations for 
preventing SSI after caesarean section in five  randomised, quasi-randomised, and cluster-
randomised trials (n=1462). In women who received skin preparation preoperatively the use 
of incisional drapes made no significant difference to SSI rates (RR=1.29, 95% CI 0.97 to 
1.71, p=0.084). One trial (n=79) comparing alcohol scrub plus a povidone-iodine incise drape 
versus povidone-iodine scrub without drape reported no infections in either group. No 
conclusions can be confidently drawn because of heterogeneity and low numbers of patients 
studied, which reflects the conclusions of the systematic review mentioned earlier 
27
 .This 
latter review included an RCT (n=849) 
29
 which compared alcoholic 2% chlorhexidine, 
administered from a disposable device, with a conventional aqueous povidone-iodine skin 
preparation. The chlorhexidine group significantly reduced SSIs but the comparison with an 
aqueous-based antiseptic was flawed; nevertheless, this device has had a wide uptake in 
surgery in general.  The most effective antiseptic for skin preparation before surgical incision 
is uncertain, but alcohol-based antiseptics are likely to be more effective than aqueous 
solutions. 
 
Antibiotic prophylaxis in breast and hernia surgery 
Antibiotic prophylaxis for breast or hernia surgery remains controversial. A Cochrane review 
assessed 17 RCTs (n=7843) for the effect of antibiotic prophylaxis on SSIs in adult patients 
undergoing elective open inguinal or femoral hernia repair. SSIs were significantly lower 
with antibiotic prophylaxis (3.1% versus 4.5% respectively; OR=0.64, 95% CI 0.50 to 0.82, 
p=0.00042) although infections after herniorrhaphy (no mesh) were not significantly different 
30
.  
Two studies have assessed antibiotic prophylaxis to prevent surgical site infection after breast 
cancer surgery. A Cochrane review 
31
 examined seven RCTs (n=1945) which compared 
preoperative or perioperative antibiotic prophylaxis with none or placebo. A significantly 
reduced incidence of SSI was found after prophylactic antibiotics (RR=0.72, 95% CI 0.53 to 
0.97, p=0.031). However, a double-blind RCT (n=254) 
32 
found no difference in SSIs 
between placebo and antibiotic (17/127; 13.4%; p=0.719). There were flaws in the studies; 
some were old and various antibiotics were used. The risk of antimicrobial resistance and its 
cost have to be considered and prophylactic use in clean surgery is still not clear cut.  
                                                                                                                                                                                                                       
Negative pressure wound therapy (NPWT)                                                                                     
NPWT is widely used in the treatment of chronic wounds to promote wound healing, wound 
debridement, alleviate exudate and odour and improve quality of life 
33, 34
. It delivers 
intermittent or continuous negative pressure (ranging from <50mmHg to >125mmHg) to the 
wound site which is covered with a foam or gauze dressing and sealed with an occlusive 
drape. Success has been reported in complex wounds 
35
 with emerging evidence to show that 
its use in high risk, post-operative incisions prevents SSIs 
36-40
. The likely modes of action are 
through holding wound edges together (thereby reducing the likelihood of surgical 
dehiscence), stimulation of perfusion, reduction of lateral tension, haematoma and oedema, 
and protection of the surgical site from exogenous sources of micro-organisms. 
                                                                                                                                                                                                                       
A retrospective analysis of surgery for colorectal, pancreatic and peritoneal surface 
malignancies 
36
 found that patients treated with postoperative NPWT developed fewer 
superficial incisional SSIs compared with those who had a standard dressing (6.7% vs 19.5%, 
p< 0.015). After clean-contaminated surgery, NPWT was associated with fewer superficial 
incisional SSIs (6.0% vs 27.4%, p<0 .001), total SSIs (16.0% vs 5.5%, p<0.011), and need 
for postoperative wound interventions (16.0% vs 35.5%, p<0.011). The authors concluded 
there was a benefit but their results require validation by prospective randomized studies. In a 
prospective study of obese patients (BMI ≥ 30) having cardiac surgery through median 
sternotomy 
37
 it was found that NPWT reduced the incidence of SSI (4%) when compared to 
standard wound dressings (16%; p = 0.027; OR 4.57; 95% CI, 1.23 - 16.94). SSIs caused by 
Gram positive skin flora were found in one patient having NPWT compared with 10 in the 
standard group (p = 0.009; OR 11.39; 95% CI, 1.42 - 91.36). Portable NPWT devices have 
been successfully used to decrease incidence of groin wound infection in patients after 
vascular surgery 
38
. In patients treated conventionally, with a skin adhesive or absorbent 
dressing, 19/63 (30%) groin incisions developed an SSI; whereas 3/52 (6%) groin incisions 
treated with the NPWT device did so (p = .0011). A further retrospective review of patients 
undergoing open colectomy 
39
 showed that 69/254 (27.2%) developed an SSI; 4 (12.5%) 
occurred in patients who had wounds treated with NPWT and 65 (29.3%) in patients having 
conventional wound care.  In an orthopaedic study, patients with blunt, high-energy fractures 
of the lower limb were randomised in a multicentre RCT (n=249) to standard dressings or 
NPWT 
40
. Significantly more infections were seen in the standard dressings group (23/122; 
19%) than the NPWT group. 
However, a study of ventral hernia repair 
41 
suggested that NPWT conferred no effect on the 
development of an SSI in patients after repair of potentially contaminated and infected 
hernias (25.8% SSIs with standard incisional wound care; 20.4% after NPWT; p = 0.50). A 
12 months follow up showed no differences between the groups in late wound complications 
(31.4% standard care; 28.6% after NPWT; p = 0.74). As these early studies are relatively 
small, with some controversial findings, further well powered and designed RCTs and 
systematic reviews are needed before the use of NPWT can be routinely recommended to 
reduce the risk of SSI. 
 
Perioperative oxygen supplementation 
Optimal oxygenation during surgery is part of best practice to ensure a haemoglobin 
saturation of more than 95%. A systematic review and meta-analysis of seven RCTs 
(n=2,728) examined the role of perioperative oxygen supplementation (FiO2= 0.8) for 2 hours 
postoperatively in the recovery room to reduce SSIs. No significant difference was seen in 
the rate of SSIs between supplemented oxygen and control groups (15.5% versus 17.5% 
respectively; odds ratio=0.85, 95% CI 0.52 to 1.38, p=0.51). However, 2 subgroup analyses 
did show a significant benefit, when studies of neuraxial anaesthesia were excluded and in 
colorectal surgery, which justifies further research. 
Flaws in the trials included heterogeneity of antibiotic use, definition of SSI, patient 
population, and duration of perioperative oxygen supplementation. 
Antiseptic surgical dressings 
It is conventional to cover incisions with a dressing at the end of an operation. Whether a 
dressing is necessary at all, or whether it should be a transparent polyurethane or absorptive 
island dressing, is unclear. A Cochrane review of 16 RCTs (n=2578) 
43
 investigated the value 
of wound dressings for the prevention of SSIs and found that there was no evidence that 
covering wounds reduced SSIs. There were many methodological flaws in these trials, 
including heterogeneity, small size and poor scientific quality; many were old studies. 
There are many studies of antiseptic dressing use in chronic wound management, although 
many are of poor quality, but few have been used to prevent SSI. However, silver Nylon 
dressings have been investigated in a small RCT (n=110) involving patients undergoing 
colorectal surgery 
44
 for prevention of SSI. Infections were lower when silver Nylon 
dressings had been used (7/55; 13%) compared with gauze (18/54; 33%; p=0.011). Again 
there were many flaws and further evidence is needed to advocate the use of antiseptic 
dressings.      
 
Wound guards 
The concept of a wound barrier, used during surgery to protect the wound edges from 
contamination, is attractive, but wound guards, based on semi-rigid plastic rings inserted into 
the incision with drapes attached to the circumference, have not been part of routine surgical 
practice. A systematic review and meta-analysis 
45
 found 10 RCTs and 2 controlled trials 
(n=1933) of the use of wound guards to prevent SSIs after open abdominal, mostly 
colorectal, surgery. Most studies were old and of poor quality, with variable definitions and 
risk of bias, but an exploratory meta-analysis using a random effects model suggested a 
potentially significant benefit (RR=0.60, 95% CI 0.41 to 0.86, p=0.005). The same group 
have since published an acceptable RCT, the ROSSINI trial, which showed definitively that 
there was no benefit conferred by wound edge protection devices in the prevention of SSI 
46
. 
Scalpel or diathermy for skin incision 
The use of diathermy for surgical incision may allow quicker surgical access and less 
bleeding than the use of a scalpel, but the effect on wound complications and SSIs has been 
investigated in a Cochrane review 
47
 of 9 RCTs (n=1901).No difference was seen between 
patients whose abdominal incisions were made with diathermy or with a scalpel (RR=0.90, 
95% CI 0.68 to 1.18, p=0.44; 7 RCTs, n=1559). The trials were flawed by being 
underpowered, with heterogeneity, and definitions were not consistent. The use of diathermy 
to reduce the risk of SSI needs further evaluation in good quality studies. 
Antimicrobial sutures 
There is laboratory-based evidence that antimicrobial sutures (impregnated or coated with the 
broad spectrum antiseptic triclosan) can effectively and safely deliver an antimicrobial into 
tissues. Several flawed and underpowered early studies showed some promise but now there 
are three independently undertaken systematic reviews and meta-analyses which found level 
1A evidence for their use. The first 
48
 identified 17 RCTs (n=3720). In a fixed effects model 
antimicrobial sutures significantly reduced SSIs by 30% (RR=0.70, 95% CI 0.57 to 0.85, 
p<0.001). Sub-analyses suggested that the effect was only significant after abdominal surgery 
but not after breast or cardiac surgery. Some studies were flawed by being underpowered 
with varying definitions of SSI and use of unconventional comparators. The second 
49
 
identified 13 RCTs (n=3568) of better quality and one additional trial of colorectal surgery. 
In a fixed effects model there was a significant reduction of SSIs associated with the use of 
antimicrobial sutures (RR=0.73, 95% CI 0.59 to 0.91, p=0.005). The third meta-analysis 
50
 
identified 15 RCTs (n=4800) using PRISMA guidelines. In a fixed effects model the use of 
antimicrobial sutures significantly reduced SSIs by 33% (RR=0.67, 95 CI 0.53 to 0.84, 
p<0.0005) with no evidence of publication bias, a sensitivity analysis robust up to removal of 
three trials and the effect being significant in subsets of clean, clean-contaminated and 
contaminated surgery. This evidence presents a strong case for the use of antimicrobial-
coated sutures to reduce SSIs.  
 
CONCLUSION 
Evidence-based medicine, derived from systematic reviews and meta-analysis, provides the 
strongest data for the compilation of guidelines. Wherever there are gaps in knowledge 
recommendations have to be based on operator experience, patient preferences and data form 
less convincing cohort and non-comparative studies. However, many of the RCTs included in 
meta-analysis are also of less than perfect scientific quality and guidelines should reflect that. 
It is interesting that many aspects of current research to prevent SSIs involve a return to the 
use of antiseptics which has commented on before 
51, 52 
and is timely bearing in mind the 
world-wide concern of rising antibiotic resistance and the lack of new antibiotic groups 
entering the research train 
53
. 
There is an attractive logic to having several evidence-based interventions in a care bundle 
because when enacted together they might act with a summation effect and reduce the risk of 
an SSI to a very low level. However, unless there is near-complete to complete compliance 
with a bundle there seems little point introducing innovations which may have large resource 
implications to implement.   
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